[1]
S. H. Priyono, O. T. J. Putra, A. Yasmina, H. Poerwosusanta, E. Y. Rahman, and I. K. Oktaviyanti, “BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer”, MKB, vol. 54, no. 4, pp. 221–227, Dec. 2022.